These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 11850819)
1. C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP. Engedal N; Korkmaz CG; Saatcioglu F Oncogene; 2002 Feb; 21(7):1017-27. PubMed ID: 11850819 [TBL] [Abstract][Full Text] [Related]
2. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer. Maeda H; Hori S; Nishitoh H; Ichijo H; Ogawa O; Kakehi Y; Kakizuka A Cancer Res; 2001 Jul; 61(14):5432-40. PubMed ID: 11454688 [TBL] [Abstract][Full Text] [Related]
3. Baculovirus p35 and Z-VAD-fmk inhibit thapsigargin-induced apoptosis of breast cancer cells. Qi XM; He H; Zhong H; Distelhorst CW Oncogene; 1997 Sep; 15(10):1207-12. PubMed ID: 9294614 [TBL] [Abstract][Full Text] [Related]
4. Phorbol ester-induced apoptosis is accompanied by NGFI-A and c-fos activation in androgen-sensitive prostate cancer cells. Day ML; Zhao X; Wu S; Swanson PE; Humphrey PA Cell Growth Differ; 1994 Jul; 5(7):735-41. PubMed ID: 7947388 [TBL] [Abstract][Full Text] [Related]
5. Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells. Mandlekar S; Yu R; Tan TH; Kong AN Cancer Res; 2000 Nov; 60(21):5995-6000. PubMed ID: 11085519 [TBL] [Abstract][Full Text] [Related]
7. The protein kinase C activator, phorbol ester, elicits disparate functional responses in androgen-sensitive and androgen-independent human prostatic cancer cells. Henttu P; Vihko P Biochem Biophys Res Commun; 1998 Mar; 244(1):167-71. PubMed ID: 9514905 [TBL] [Abstract][Full Text] [Related]
8. Tumor-promoting phorbol ester-induced cell death and gene expression in a human prostate adenocarcinoma cell line. Young CY; Murtha PE; Zhang J Oncol Res; 1994; 6(4-5):203-10. PubMed ID: 7841543 [TBL] [Abstract][Full Text] [Related]
9. Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells. Jiang C; Wang Z; Ganther H; Lu J Cancer Res; 2001 Apr; 61(7):3062-70. PubMed ID: 11306488 [TBL] [Abstract][Full Text] [Related]
10. Androgen blocks apoptosis of hormone-dependent prostate cancer cells. Kimura K; Markowski M; Bowen C; Gelmann EP Cancer Res; 2001 Jul; 61(14):5611-8. PubMed ID: 11454715 [TBL] [Abstract][Full Text] [Related]
11. Activation of SAPK/JNK by camptothecin sensitizes androgen-independent prostate cancer cells to Fas-induced apoptosis. Costa-Pereira AP; McKenna SL; Cotter TG Br J Cancer; 2000 Jun; 82(11):1827-34. PubMed ID: 10839298 [TBL] [Abstract][Full Text] [Related]
12. Up-regulation of p21(WAF1/CIP1) levels leads to growth suppression of prostate cancer cell lines. Sugibayashi R; Kiguchi Y; Shimizu T; Suzuki T; Hamada H; Takeda K Anticancer Res; 2002; 22(2A):713-9. PubMed ID: 12014641 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of caspases by cytokine response modifier A blocks androgen ablation-mediated prostate cancer cell death in vivo. Srikanth S; Kraft AS Cancer Res; 1998 Feb; 58(4):834-9. PubMed ID: 9485043 [TBL] [Abstract][Full Text] [Related]
14. Tyrphostin AG825 triggers p38 mitogen-activated protein kinase-dependent apoptosis in androgen-independent prostate cancer cells C4 and C4-2. Murillo H; Schmidt LJ; Tindall DJ Cancer Res; 2001 Oct; 61(20):7408-12. PubMed ID: 11606371 [TBL] [Abstract][Full Text] [Related]
15. Persistent membrane translocation of protein kinase C alpha during 12-0-tetradecanoylphorbol-13-acetate-induced apoptosis of LNCaP human prostate cancer cells. Powell CT; Brittis NJ; Stec D; Hug H; Heston WD; Fair WR Cell Growth Differ; 1996 Apr; 7(4):419-28. PubMed ID: 9052983 [TBL] [Abstract][Full Text] [Related]
16. Radiation-induced apoptosis mediated by retinoblastoma protein. Bowen C; Spiegel S; Gelmann EP Cancer Res; 1998 Aug; 58(15):3275-81. PubMed ID: 9699655 [TBL] [Abstract][Full Text] [Related]
17. Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway. Kim IY; Seong DH; Kim BC; Lee DK; Remaley AT; Leach F; Morton RA; Kim SJ Cancer Res; 2002 Jul; 62(13):3649-53. PubMed ID: 12097269 [TBL] [Abstract][Full Text] [Related]
18. Signaling pathway activated during apoptosis of the prostate cancer cell line LNCaP: overexpression of caspase-7 as a new gene therapy strategy for prostate cancer. Marcelli M; Cunningham GR; Walkup M; He Z; Sturgis L; Kagan C; Mannucci R; Nicoletti I; Teng B; Denner L Cancer Res; 1999 Jan; 59(2):382-90. PubMed ID: 9927051 [TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated tissue-targeted expression of a caspase-9-based artificial death switch for the treatment of prostate cancer. Xie X; Zhao X; Liu Y; Zhang J; Matusik RJ; Slawin KM; Spencer DM Cancer Res; 2001 Sep; 61(18):6795-804. PubMed ID: 11559553 [TBL] [Abstract][Full Text] [Related]
20. Neutral endopeptidase promotes phorbol ester-induced apoptosis in prostate cancer cells by inhibiting neuropeptide-induced protein kinase C delta degradation. Sumitomo M; Shen R; Goldberg JS; Dai J; Navarro D; Nanus DM Cancer Res; 2000 Dec; 60(23):6590-6. PubMed ID: 11118039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]